Holle R - Search Results

1

Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.

Wolf M, Havemann K, Holle R, Gropp C, Drings P, Hans K, Schroeder M, Heim M, Dommes M, Mende S, et al. Wolf M, et al. Among authors: holle r. J Clin Oncol. 1987 Dec;5(12):1880-9. doi: 10.1200/JCO.1987.5.12.1880. J Clin Oncol. 1987. PMID: 2824710 Clinical Trial.

2

Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival.

Wolf M, Holle R, Hans K, Drings P, Havemann K. Wolf M, et al. Among authors: holle r. Br J Cancer. 1991 Jun;63(6):986-92. doi: 10.1038/bjc.1991.215. Br J Cancer. 1991. PMID: 1648949 Free PMC article. Clinical Trial.

3

The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.

Wolf M, Havemann K, Holle R, Harms V, Drings P, Hans K, Dombrowski H, Victor N. Wolf M, et al. Among authors: holle r. Eur J Cancer Clin Oncol. 1987 Aug;23(8):1197-205. doi: 10.1016/0277-5379(87)90155-6. Eur J Cancer Clin Oncol. 1987. PMID: 2443363 Clinical Trial.

4

Experience of a German multicenter study group with ifosfamide in small cell lung cancer.

Havemann K, Wolf M, Drings P, Hans K, Schroeder M, Holle R, Flechtner H, Goerg R, Becker H. Havemann K, et al. Among authors: holle r. Semin Oncol. 1989 Feb;16(1 Suppl 3):9-18. Semin Oncol. 1989. PMID: 2539648 Clinical Trial.

5

[Incidence of recurrence and long-term survival in small cell bronchial carcinoma].

Wolf M, Havemann K, Holle R, Drings P, Hans K, Schroeder M. Wolf M, et al. Among authors: holle r. Onkologie. 1987 Dec;10(6):357-66. doi: 10.1159/000216444. Onkologie. 1987. PMID: 2831490 Clinical Trial. German.

6

Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.

Havemann K, Wolf M, Holle R, Gropp C, Drings P, Manke HG, Hans K, Schroeder M, Heim M, Victor N, et al. Havemann K, et al. Among authors: holle r. Cancer. 1987 Mar 15;59(6):1072-82. doi: 10.1002/1097-0142(19870315)59:6<1072::aid-cncr2820590605>3.0.co;2-w. Cancer. 1987. PMID: 3028596 Clinical Trial.

7

Two randomized trials for alternating polychemotherapy of small cell lung cancer.

Havemann K, Gropp C, Klapsing J, Viktor N, Holle R, Drings P, Manke HG, Hans K, Schroeder M, Heim M. Havemann K, et al. Among authors: holle r. Cancer Chemother Pharmacol. 1986;18 Suppl 2:S40-4. doi: 10.1007/BF00647450. Cancer Chemother Pharmacol. 1986. PMID: 3028663 Clinical Trial.

8

Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.

Wolf M, Hans K, Becker H, Hässler R, von Bültzingslöwen F, Goerg R, Klaasen HA, Dannhäuser J, Holle R, Pfab R, et al. Wolf M, et al. Among authors: holle r. Semin Oncol. 1994 Jun;21(3 Suppl 4):42-7. Semin Oncol. 1994. PMID: 8209276 Clinical Trial.

9

Clinical relevance of histologic subtyping in small cell lung cancer.

Bepler G, Neumann K, Holle R, Havemann K, Kalbfleisch H. Bepler G, et al. Among authors: holle r. Cancer. 1989 Jul 1;64(1):74-9. doi: 10.1002/1097-0142(19890701)64:1<74::aid-cncr2820640113>3.0.co;2-q. Cancer. 1989. PMID: 2543496

10

Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer.

Jaques G, Bepler G, Holle R, Wolf M, Hannich T, Gropp C, Havemann K. Jaques G, et al. Among authors: holle r. Cancer. 1988 Jul 1;62(1):125-34. doi: 10.1002/1097-0142(19880701)62:1<125::aid-cncr2820620122>3.0.co;2-x. Cancer. 1988. PMID: 2838147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters